Literature DB >> 10502125

Long-term prognosis of hemolytic uremic syndrome and effective renal plasma flow.

D Hüseman1, J Gellermann, I Vollmer, I Ohde, S Devaux, J H Ehrich, G Filler.   

Abstract

The long-term prognosis of diarrhea-associated hemolytic uremic syndrome (D+ HUS) was evaluated in a cohort of 127 of 149 children who had survived the acute phase. Glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) were estimated by serial (51)Cr-EDTA and (123)iodine-hippurate clearances. All children had acute renal failure during the initial phase and 74% of patients were dialyzed. During the 1st year, mean GFR and ERPF increased continuously until a plateau was reached. In the 2nd year after the diagnosis of HUS, GFR was below 80 and ERPF below 515 ml/min per 1. 73 m(2) in 16% and 47% of patients, respectively. At the end of a median follow-up of 5.0 (range 2.0-13.2) years, the proportion of children with renal sequelae such as proteinuria >/=300 mg/l, hypertension, or a GFR <80 ml/min per 1.73 m(2) was 23%. Anuria of more than 7 days' duration and hypertension during the acute phase were statistically significant risk factors for an unfavorable outcome. A reduced ERPF in the 2nd year was found in 93% of patients with sequelae. Mean filtration fraction (SD) in these patients was 0. 26 (+/-0.07) versus 0.19 (+/-0.05) in patients without sequelae (P<0. 0001). These data suggest that loss of nephrons during the acute phase may implicate hyperfiltration in the residual functioning kidney mass leading to progressive renal disease. ERPF in the 2nd year after D+ HUS may serve as an excellent parameter to detect patients with a high risk of an unfavorable long-term outcome.

Entities:  

Mesh:

Year:  1999        PMID: 10502125     DOI: 10.1007/s004670050679

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  16 in total

Review 1.  Guidelines for the management and investigation of hemolytic uremic syndrome.

Authors:  Takashi Igarashi; Shuichi Ito; Mayumi Sako; Akihiko Saitoh; Hiroshi Hataya; Masashi Mizuguchi; Tsuneo Morishima; Kenji Ohnishi; Naohisa Kawamura; Hirotsugu Kitayama; Akira Ashida; Shinya Kaname; Hiromichi Taneichi; Julian Tang; Makoto Ohnishi
Journal:  Clin Exp Nephrol       Date:  2014-08       Impact factor: 2.801

2.  Prognostic significance of microalbuminuria in postdiarrheal hemolytic uremic syndrome.

Authors:  Randall Lou-Meda; Robert S Oakes; Jarom N Gilstrap; Christopher G Williams; Richard L Siegler
Journal:  Pediatr Nephrol       Date:  2006-09-12       Impact factor: 3.714

3.  Hyperfiltration affects accuracy of creatinine eGFR measurement.

Authors:  Shih-Han S Huang; Ajay P Sharma; Abeer Yasin; Robert M Lindsay; William F Clark; Guido Filler
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-21       Impact factor: 8.237

4.  Risk factors for poor renal prognosis in children with hemolytic uremic syndrome.

Authors:  Alessandra Gianviti; Alberto E Tozzi; Laura De Petris; Alfredo Caprioli; Lucilla Ravà; Alberto Edefonti; Gianluigi Ardissino; Giovanni Montini; Graziella Zacchello; Alfonso Ferretti; Carmine Pecoraro; Tommaso De Palo; Angela Caringella; Maurizio Gaido; Rosanna Coppo; Francesco Perfumo; Nunzia Miglietti; Ilse Ratsche; Rosa Penza; Giovambattista Capasso; Silvio Maringhini; Salvatore Li Volti; Carmen Setzu; Marco Pennesi; Alberto Bettinelli; Leopoldo Peratoner; Ivana Pela; Elio Salvaggio; Giuliana Lama; Salvatore Maffei; Gianfranco Rizzoni
Journal:  Pediatr Nephrol       Date:  2003-10-31       Impact factor: 3.714

Review 5.  Long-term outcomes of Shiga toxin hemolytic uremic syndrome.

Authors:  Joann M Spinale; Rebecca L Ruebner; Lawrence Copelovitch; Bernard S Kaplan
Journal:  Pediatr Nephrol       Date:  2013-01-04       Impact factor: 3.714

6.  Two different therapeutic regimes in patients with sequelae of hemolytic-uremic syndrome.

Authors:  María Gracia Caletti; Horacio Lejarraga; Diana Kelmansky; Mabel Missoni
Journal:  Pediatr Nephrol       Date:  2004-06-18       Impact factor: 3.714

Review 7.  The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children.

Authors:  Chantal Loirat; Patrick Niaudet
Journal:  Pediatr Nephrol       Date:  2003-09-17       Impact factor: 3.714

8.  Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil.

Authors:  Jutta Gellermann; Uwe Querfeld
Journal:  Pediatr Nephrol       Date:  2004-01       Impact factor: 3.714

9.  Characterization of the cytokine immune response in children who have experienced an episode of typical hemolytic-uremic syndrome.

Authors:  Soeren Westerholt; Anne-Kathrin Pieper; Martin Griebel; Hans-Dieter Volk; Thomas Hartung; Renate Oberhoffer
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

10.  Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome.

Authors:  Robert S Oakes; Justin K Kirkham; Justin K Kirkhamm; Raoul D Nelson; Richard L Siegler
Journal:  Pediatr Nephrol       Date:  2008-05-09       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.